Advertisement

Angiogenesis-Regulating Cytokines: Activities and Interactions

  • M. S. Pepper
  • S. J. Mandriota
  • J.-D. Vassalli
  • L. Orci
  • R. Montesano
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 213/2)

Abstract

The establishment of a vascular supply is an absolute requirement for the growth of normal and neoplastic tissues and, as might be expected, the cardiovascular system is the first organ system to develop and to become functional during embryogenesis. It has been known since the beginning of this century (Evans 1909) that, both during development and in postnatal life, all blood vessels begin as simple endothelial-lined capillaries. Although some remain as capillaries, many of these newly formed vessels develop into larger vessels, in part through the addition of a variable number of concentrically disposed smooth muscle cell layers. The heterogeneity and variable complexity of blood vessels thus generated serves to ensure structural and functional diversity in the vascular tree.

Keywords

Endothelial Cell Vascular Endothelial Growth Factor Transform Growth Factor Basic Fibroblast Growth Factor Endothelial Cell Proliferation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander HR, Billingsley KG, Block MI, Fraker DL (1994) D-factor/leukemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease. Cytokine 6: 589–596PubMedGoogle Scholar
  2. Andrade SP, Fan T-PD, Lewis GP (1987) Quantitative in vivo studies on angiogenesis in a rat sponge model. Br J Exp Pathol 68: 755–766PubMedGoogle Scholar
  3. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1994) In vivo synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in rabbit ischemic hindlimb. Circulation 4: 1–585Google Scholar
  4. Attisano L, Wrana JL, Lopez-Casillas F, Massague J (1994) TGF~p receptors and actions. Biochim Biophys Acta 1222: 71–80PubMedGoogle Scholar
  5. Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis. Microvasc Res 14: 52–65Google Scholar
  6. Baird A, Durkin T (1986) Inhibition of endothelial cell proliferation by type β-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 138: 476–482PubMedGoogle Scholar
  7. Baird A, Klagsbrun M (1991) The fibroblast growth factor family. Cancer Cells 3: 239–243PubMedGoogle Scholar
  8. Barleon B, Hauser S, Schollmann C, Weindel K, Marme D, Yayon A, Weich HA (1994) Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J Cell Biochem 54: 56–66PubMedGoogle Scholar
  9. Basilico C, Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115–165PubMedGoogle Scholar
  10. Bouck N (1990) Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2: 179–185PubMedGoogle Scholar
  11. Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF (1992) Immunolocalization of basic fibroblast growth factor to the microvasculture of human brain tumors. Cancer 70: 2673–2680PubMedGoogle Scholar
  12. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P (1993) Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest 92: 2408–2418PubMedGoogle Scholar
  13. Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208: 516–518PubMedGoogle Scholar
  14. Brown MA, Metcalf D, Gough NM (1994) Leukemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6: 300–309PubMedGoogle Scholar
  15. Brown TJ, Rowe JM, Shoyab M, Gladstone P (1990) Oncostatin M: a novel regulator of endothelial cell properties. In: Roberts R, Schneider D (eds) Molecular biology of the cardiovascular system. UCLA Symposia on molecular and cellular biology, New Series, vol 131, New York, pp 195–206Google Scholar
  16. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massagué J (1990) Distinct transforming growth factor-ß (TGF-ß) receptor subsets as determinants of cellular responsiveness to three TGF-ß isoforms. J Biol Chem 265: 20533–20538PubMedGoogle Scholar
  17. Cheifetz S, Bellóin T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M (1992) Endoglin is a component of the transforming growth factor-ß receptor system in human endothelial cells. J Biol Chem 267: 19027–19030PubMedGoogle Scholar
  18. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H, Sasse J (1988) Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 48: 2083–2088PubMedGoogle Scholar
  19. Christofori G, Hanahan D (1994) Molecular dissection of multi-stage tumorigenesis in transgenic mice. Semin Cancer Biol 5: 3–12PubMedGoogle Scholar
  20. Clark RAF, DellaPelle P, Manseau E, Lanigan JM, Dvorak HF, Colvin RB (1982a) Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol 79: 269–276PubMedGoogle Scholar
  21. Clark RAF, Quinn JF, Winn HJ, Lanigan JM, Dellepeila P, Colvin RB (1982b) Fibronectin is produced by blood vessels in response to injury. J Exp Med 156: 646–651PubMedGoogle Scholar
  22. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z (1990) Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 63: 823–840Google Scholar
  23. Cozzolino F, Torcia M, Lucibello M, Ziehe M, Piatt J, Fabiani S, Brett J, Stern D (1993) Interferon-α and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest 91: 2504–2512PubMedGoogle Scholar
  24. Cullinan-Bove K, Koos RD (1993) Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133: 829–837PubMedGoogle Scholar
  25. Deng C-X, Wynshaw-Boris A, Shen MM, Daugherty C, Ornitz DM, Leder P (1994) Murine FGFR-1 is required for early postimplantion growth and axial organization. Genes Dev 8: 3045–3057PubMedGoogle Scholar
  26. Dennis PA, Rifkin DB (1990) Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth. J Cell Physiol 144: 84–98PubMedGoogle Scholar
  27. Derynck R (1994) TGF-ß-receptor mediated signaling. Trends Biochem Sci 19: 548–553PubMedGoogle Scholar
  28. Dolecki GJ, Connolly DT (1991) Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem Biophy Res Commun 180: 572–578Google Scholar
  29. Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D (1991) Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6: 1195–1202PubMedGoogle Scholar
  30. Engerman RL, Pfaffenbach D, Davis MD (1967) Cell turnover of capillaries. Lab Invest 17: 738–743PubMedGoogle Scholar
  31. Evans HM (1909) On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries. Anat Ree 3: 498–518Google Scholar
  32. Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326: 1456–1463PubMedGoogle Scholar
  33. Fafeur V, Terman BL, Blum J, Böhlen P (1990) Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGFß receptor subtype and decreases the growth inhibitory response to TGF-ß1. Growth Factors 3: 237–245PubMedGoogle Scholar
  34. Fafeur V, O’Hara B, Böhlen P (1993) A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-ß and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. Mol Biol Cell 4: 135–144PubMedGoogle Scholar
  35. Femig DG, Gallagher JT (1994) Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5: 353–377Google Scholar
  36. Ferrara N, Houck K, Jackeman L, Leung DW (1992a) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13: 18–35Google Scholar
  37. Ferrara N, Winer J, Henzel WJ (1992b) Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 89: 698–702PubMedGoogle Scholar
  38. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB (1992) Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol 118: 901–909PubMedGoogle Scholar
  39. Folkman J (1974) Tumor angiogenesis. Adv Cancer Res 19: 331–358PubMedGoogle Scholar
  40. Folkman J, Haudenschild C (1980) Angiogenesis in vitro. Nature 288: 551–555PubMedGoogle Scholar
  41. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442–447PubMedGoogle Scholar
  42. Fong G-H, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66–70PubMedGoogle Scholar
  43. Fräter-Schröder M, Müller G, Birchmeier W, Böhlen P (1986) Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137: 295–302PubMedGoogle Scholar
  44. Friesel R, Komoriya A, Maciag T (1987) Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 104: 689–696PubMedGoogle Scholar
  45. Gajdusek CM, Luo Z, Mayberg MR (1993) Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol 157: 133–144PubMedGoogle Scholar
  46. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413–427PubMedGoogle Scholar
  47. Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6: 3362–3369PubMedGoogle Scholar
  48. Gonzalez A-M, Buscaglia M, Ong M, Baird A (1990) Distribution of basic fibroflast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 110: 753–765PubMedGoogle Scholar
  49. Goto F, Goto K, Weindel K, Folkman J (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508–517PubMedGoogle Scholar
  50. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265: 8361–8364PubMedGoogle Scholar
  51. Hannan RL, Kourembanas S, Flanders KC, Rogelj SJ, Roberts AB, Faller DV, Klagsbrun M (1988) Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors 1: 7–17PubMedGoogle Scholar
  52. Hannekan A, Lutty GA, McLeod DS, Robey F, Harvey AK, Hjelmeland LM (1989) Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina. J Cell Physiol 138: 115–120Google Scholar
  53. Hanneken A, Maher PA, Baird A (1995) High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells - implications for the modulation of FGF-2. J Cell Biol 128: 1221–1228PubMedGoogle Scholar
  54. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoclasts. J Clin Invest 93: 2490–2496PubMedGoogle Scholar
  55. Heimark RL, Twardzik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078–1080PubMedGoogle Scholar
  56. Heyns AP, Eldor A, Vlodavsky I, Kaiser N, Fridman R, Panet A (1985) The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. J Invest Dermatol 161: 297–306Google Scholar
  57. Hilton DJ (1992) LIF: lots of interesting functions. Trends Biochem Sci 17: 72–76PubMedGoogle Scholar
  58. Hirai R, Kaji K (1992) Transforming growth factor ß1 -specific binding proteins on human vascular endothelial cells. Exp Cell Res 201: 119–125PubMedGoogle Scholar
  59. Hobson B, Denekamp J (1984) Endothelial proliferation in tumors and normal tissues: continuous labelling studies. Br J Cancer 49: 405–413PubMedGoogle Scholar
  60. Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis supression. Nature Med 1: 149–153PubMedGoogle Scholar
  61. Hori A, Sasasda R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51: 6180–6184PubMedGoogle Scholar
  62. Höckel M, Schienger K, Doctrow S, Kissel T, Vaupel P (1993) Therapeutic angiogenesis. Arch Surg 128: 423–429PubMedGoogle Scholar
  63. Hu DE, Fan T-PD (1995) Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br J Pharmacol 114: 262–268PubMedGoogle Scholar
  64. Hu DE, Hori Y, Fan T-PD (1993) Interleukin-8 stimulates angiogenesis in rats. Inflammation 17: 135–143PubMedGoogle Scholar
  65. Hughes SE, Hall PA (1993) Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 69: 173–182PubMedGoogle Scholar
  66. Hughes SE, Crossman D, Hall PA (1993) Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 27: 1214–1219PubMedGoogle Scholar
  67. Iruela-Arispe ML, Hasselaar P, Sage H (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64: 174–186PubMedGoogle Scholar
  68. Iruela-Aripse ML, Sage EH (1993) Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-ß1. J Cell Biochem 52: 414–430Google Scholar
  69. Ivanovic V, Melman A, Davis-Joseph B, Valcic M, Geliebter J (1995) Elevated levels of TGF-ß1 in patients with invasive prostate cancer. Nature Med 1: 282–284PubMedGoogle Scholar
  70. Jaye M, Schlessinger J, Dionne CA (1992) Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135: 185–199PubMedGoogle Scholar
  71. Jennings JC, Mohan S, Linkhart TA, Widstrom TA, Baylink DJ (1988) Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol 137: 167–172PubMedGoogle Scholar
  72. Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60: 1–41PubMedGoogle Scholar
  73. Johnson HM, Bazer FW, Szente BE, Jarpe MA (1994) How interferons fight disease. Sci Am 270: 40–47Google Scholar
  74. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841–844PubMedGoogle Scholar
  75. Kingsley DM (1944) The TGF-ß superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133–146Google Scholar
  76. Klagsbrun M, D’Amore PA (1991) Regulators of angiogenesis. Annu Rev Physiol 53: 217–239PubMedGoogle Scholar
  77. Klagsbrun M, Knighton D, Folkman J (1976) Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 36: 110–114PubMedGoogle Scholar
  78. Koh GY, Kim S-J, Klug MG, Park K, Soonpaa MH, Field LJ (1995) Targeted expression of transforming growth factor-ß1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 95: 114–121PubMedGoogle Scholar
  79. Kondo S, Asano M, Suzuki H (1993) Significance of vascular endothelial growth actor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194: 1234–1241PubMedGoogle Scholar
  80. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H (1994) Vascular endothelial growth factor/vascular* permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221: 221–214Google Scholar
  81. Krnacik-Coleman S, Rosen JM (1994) Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol 8: 218–229Google Scholar
  82. Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107: 1589–1598PubMedGoogle Scholar
  83. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor ß1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770–774PubMedGoogle Scholar
  84. Lawler S, Candia AF, Ebner R, Shum L, Lopez AR, Moses HL, Wright CVE, Derynck R (1994) The murine type II TGF-ß receptor has a coincident embryonic expression and binding preference for TGF-ß1. Development 120: 165–175PubMedGoogle Scholar
  85. Leek RD, Harris AL, Lewis CE (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 56: 423–435PubMedGoogle Scholar
  86. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB (1994) Maternal rescue of transforming growth factor-ß1 null mice. Science 264: 1936–1938PubMedGoogle Scholar
  87. Liaw L, Schwartz SM (1993) Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Differences in growth regulatory molecules. Arterioscler Thromb 13: 985–993PubMedGoogle Scholar
  88. Linder V, Reidy MA (1993) Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ Res 73: 589–595Google Scholar
  89. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–366PubMedGoogle Scholar
  90. Madri JA, Pratt BM, Tucker AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-ß depends on the composition and organization of the extracellular matrix. J Cell Biol 106: 1357–1384Google Scholar
  91. Majewski S, Szmurlo NA, Marczak M, Jablonska S, Bollag W (1994) Synergistic effect of retinoids and interferon a on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor cell lines. Int J Cancer 57: 81–85PubMedGoogle Scholar
  92. Mandriota SJ, Seghezzi G, Vassalli J-D, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS (1995) Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial aells. J Biol Chem 270: 9709–9716PubMedGoogle Scholar
  93. Matsuura H, Myokai F, Arata J, Noji S, Taniguchi S (1994) Expression of type II transforming growth factor-beta receptor mRNA in human skin, as revealed by in stiu hybridization. J Dermatol Sci 8: 25–32Google Scholar
  94. Matsuzaki K, Yoshitake Y, Matuo Y, Sasaki H, Nishikawa K (1989) Monoclonal antibodies against heparin-binding growth factor Il/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86: 9911–9915PubMedGoogle Scholar
  95. May LT, Torcia G, Cozzolino F, Ray A, Tatter SB, Santhanam U, Sehgal PB, Stern D (1989) lnterleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 159: 991–998PubMedGoogle Scholar
  96. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA (1994) Endoglin, a TGF-ß binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics 8: 345–351PubMedGoogle Scholar
  97. McCartney-Francis N, Mizel D, Wong H, Wahl L, Wahl S (1990) TGF-ß regulates production of growth factors and TGF-ß by human peripheral blood monocytes. Growth Factors 4: 27–35PubMedGoogle Scholar
  98. Merwin JR, Anderson JM, Kocher O, van Itallie CM, Madri JA (1990) Transforming growth factor-ß1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 142: 117–128PubMedGoogle Scholar
  99. Merwin JR, Newman W, Beall LD, Tucker A, Madri J (1991a) Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am J Pathol 138: 37–51PubMedGoogle Scholar
  100. Merwin JR, Roberts A, Kondaiah P, Tucker A, Madri J (1991b) Vascular cell responses to TGF-ß3 mimick those of TGF-ß1 in vitro. Growth Factors 5: 149–158PubMedGoogle Scholar
  101. Mignatti P, Rifkin DB (1991) Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence; a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 47: 201–207PubMedGoogle Scholar
  102. Mignatti P, Tsuboi R, Robbins E, Rifkin DB (1989) In vitro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteases. J Cell Biol 108: 671–682PubMedGoogle Scholar
  103. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM-L, Aaronson SA (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors enconded by a single gene. Proc Natl Acad Sci USA 89: 246–250PubMedGoogle Scholar
  104. Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS (1992) Oncostatin M as a potent mitogen for AIDS-Kaposi’s sarcoma-derived cells. Science 255: 1432–1434PubMedGoogle Scholar
  105. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature 367: 576–579PubMedGoogle Scholar
  106. Montesano R, Orci L (1985) Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42: 469–477PubMedGoogle Scholar
  107. Montesano R, Orci L, Vassalli P (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97: 1648–1652PubMedGoogle Scholar
  108. Montesano R, Vassalli J-D, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297–7301PubMedGoogle Scholar
  109. Montesano R, Pepper MS, Vassalli J-D, Orci L (1987) Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 132: 509–516PubMedGoogle Scholar
  110. Morrison RS, Yamaguchi F, Bruner JM, Tang M, McKeehan W, Berger MS (1994) Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human gliblastoma multiforme. Cancer Res 54: 2794–2799PubMedGoogle Scholar
  111. Moscatelli D, Presta M, Joseph-Silverstein J, Rifkin DB (1986a) Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol 129: 273–276PubMedGoogle Scholar
  112. Moscatelli D, Presta M, Rifkin DB (1986b) Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc Natl Acad Sci USA 83: 2091–2095PubMedGoogle Scholar
  113. Müller G, Behrens J, Nussbaumer U, Böhlen P, Birchmeier W (1987) Inhibitory action of transforming growth factor-ß on endothelial cells. Proc Natl Acäd Sci USA 84: 5600–5604PubMedGoogle Scholar
  114. Mustonen T, Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895–898PubMedGoogle Scholar
  115. Myoken Y, Kan M, Sato GH, McKeehan WL, Sato D (1990) Bifunctional effects of transforming growth factor-ß (TGF-ß) on endothelial cell growth correlate with phenotypes of TGF-ß binding sites. Exp Cell Res 191: 299–304PubMedGoogle Scholar
  116. Nabel EG, Shum L, Pompili VJ, Yang Z-Y, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ (1993) Direct gene transfer of transforming growth factor ß1 into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90: 10759–10763PubMedGoogle Scholar
  117. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113: 981–986PubMedGoogle Scholar
  118. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ (1994) Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5: 89–97PubMedGoogle Scholar
  119. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356–361PubMedGoogle Scholar
  120. Nicosia RF, Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta. Lab Invest 63: 115–122PubMedGoogle Scholar
  121. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H (1993) Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68: 520–527PubMedGoogle Scholar
  122. Orchard PJ, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro R (1989) Treatment of hemangioendotheliomas with alpha interferon. Lancet 2: 565–567PubMedGoogle Scholar
  123. O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal R, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metasases by a Lewis lung carinoma. Cell 79: 315–328PubMedGoogle Scholar
  124. Paku S, Paweletz N (1991) First steps of tumor-related angiogenesis. Lab Invest 65: 334–346PubMedGoogle Scholar
  125. Pardenaud L, Yassine F, Dieterlen-Lievre F (1989) Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105: 437–485Google Scholar
  126. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K (1992) Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 4: 69–83PubMedGoogle Scholar
  127. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519–528PubMedGoogle Scholar
  128. Pellegrini S, Schindler C (1993) Early events in signaling by interferons. Trends Biochem Sci 18: 338–342PubMedGoogle Scholar
  129. Pepper MS, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Diff Dev 32: 319–328Google Scholar
  130. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D (1990) Transforming growth factor betal modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111: 743–755PubMedGoogle Scholar
  131. Pepper MS, Montesano R, Vassalli J-D, Orci L (1991) Chondrocytes inhibit endothelial sprout formation in vitro: evidence for the involvement of a transforming growth factor-beta. J Cell Physiol 146: 170–179PubMedGoogle Scholar
  132. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189: 824–831PubMedGoogle Scholar
  133. Pepper MS, Vassalli J-D, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 204: 356–363PubMedGoogle Scholar
  134. Pepper MS, Vassalli J-D, Orci L, Montesano R (1994a) Angiogenesis in vitro: cytokine interactions and balanced extracellular proteolysis. In: Maragoudakis ME, Gullino PM, Lelkes PI (eds) Angiogenesis. Molecular biology, clinical aspects. Plenum, New York, pp 149–170 (NATO ASI series A: life sciences, vol 263)Google Scholar
  135. Pepper MS, Vassalli J-D, Wilks JW, Schweigerer L, Orci L, Montesano R (1994b) Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 55: 419–434PubMedGoogle Scholar
  136. Pepper MS, Ferrara N, Orci L, Montesano R (1995) Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108: 73–83PubMedGoogle Scholar
  137. Peters KG, Werner S, Chen G, Williams LT (1992) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114: 233–243PubMedGoogle Scholar
  138. Phillips GD, Whitehead RA, Knighton DR (1992) Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-p induced angiogenesis. Growth Factors 6: 77–84PubMedGoogle Scholar
  139. Phillips GD, Whitehead RA, Stone AM, Ruebel MW, Goodkin ML, Knighton DR (1993) Transforming growth factor beta (TGF-B) stimulation of angiogenesis: an electron microscopic study. J Submicrosc Cytol Pathol 25: 149–155PubMedGoogle Scholar
  140. Plate, KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potent tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845–848PubMedGoogle Scholar
  141. Plate KH, Breier G, Risau W (1994a) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4: 207–218PubMedGoogle Scholar
  142. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994b) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520–529PubMedGoogle Scholar
  143. Postlewaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor ß. J Exp Med 165: 251–256Google Scholar
  144. Qu Z, Picou M, Dang TT, Angell E, Planck SR, Hart CE, Rosenbaum JT (1994) Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvent arthritis in the Lewis rat. Am J Pathol 145: 1127–1139PubMedGoogle Scholar
  145. Quarto N, Amarlic (1994) Heparan sulfate proteoglycans as transducers of FGF-2 signaling. J Cell Sci 107: 3201–3212PubMedGoogle Scholar
  146. RayChaudhury A, D’Amore PA (1991) Endothelial cell regulation by transforming growth-factor-beta. J Cell Biochem 47: 224–229PubMedGoogle Scholar
  147. Reilly TM, Taylor DS, Herblin WF, Thoolen MJ, Chiu AT, Watson DW, Timmermans PBMWM (1989) Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem Biophys Res Commun 164: 736–743PubMedGoogle Scholar
  148. Ricketts RR, Hatley RM, Corden BJ, Sabio H, Howell CG (1994) lnterferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 219: 605–614PubMedGoogle Scholar
  149. Risau W, Lemmon V (1988) Changes in the vascular extracellular matrix during embryonic vasculo-genesis and angiogenesis. Dev Biol 125: 441–450PubMedGoogle Scholar
  150. Risau W, Sariola H, Zerwes H-G, Sasse J, Ekblom P, Kemler R, Doetschman T (1988) Vasculogenesis and angiogenesis in embryonic stem cell derived embryoid bodies. Development 102: 471–478PubMedGoogle Scholar
  151. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type ß: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171PubMedGoogle Scholar
  152. Roberts AB, Sporn AB (1989) Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-ß. Am Rev Respir Dis 140: 1126–1128PubMedGoogle Scholar
  153. Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Cell Sci 108: 2369–2379Google Scholar
  154. Rosen EM, Liu D, Setter E, Bhargava M, Goldberg ID (1991) lnterleukin-6 stimulates motility of vascular endothelium. Experientia Suppl 59: 194–205Google Scholar
  155. Ruszczak Z, Detmar M, Imcke E, Orfanos CE (1990) Effects of rIFN alpha, beta and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 95: 693–699PubMedGoogle Scholar
  156. Ruta M, Howk R, Ricca G, Drohan W, Zabelshansky M, Laureys G, Barton DE, Francke U, Schlessinger J, Givol D (1988) A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene 3: 9–15Google Scholar
  157. Sanderson N, Factor V, Nagy P, Kopp J, Kondai P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS (1995) Hepatic expression of mature transforming growth factor ß1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92: 2572–2576PubMedGoogle Scholar
  158. Sanvito F, Nichols A, Herrera P-L, Huarte J, Wohlwend A, Vassalli J-D, Orci L (1995) TGF-ß 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-a, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 217: 1279–1286PubMedGoogle Scholar
  159. Sariola H, Peault B, LeDouarin N, Buck C, Dieterlen-Lievre F, Saxen L (1984) Extracellular matrix and capillary ingrowth in interspecies chimeric kidneys. Cell Differ 15: 43–51PubMedGoogle Scholar
  160. Sato Y, Rifkin DB (1988) Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107: 119–1205Google Scholar
  161. Schultz-Hector S, Haghayegh S (1993) ß-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 53: 1444–1449PubMedGoogle Scholar
  162. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C (1990) In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137: 85–92PubMedGoogle Scholar
  163. Schwartz SM, Benditt EP (1977) Aortic endothelial cell replication, I. Effects of age and hypertension in the rat. Circ Res 41: 248–255PubMedGoogle Scholar
  164. Schweigprer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D (1987) Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325: 257–259Google Scholar
  165. Segarini PR, Rosen DM, Seydin SM (1989) Binding of transforming growth factor-ß to cell surface proteins varies with cell type. Mol Endocrinol 3: 261–272PubMedGoogle Scholar
  166. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Dvorak AM, Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303–324PubMedGoogle Scholar
  167. Shalaby F, Rossant J, Yamaguchi TP, Gertseristein M, Wu X-F, Breitmari ML, Schuch AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62–66PubMedGoogle Scholar
  168. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T (1992) Targeted disruption of the mouse transforming growth factor-ß1 gene results in multifocal inflammatory disease. Nature 359: 693–699PubMedGoogle Scholar
  169. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845PubMedGoogle Scholar
  170. Sidkey YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects of tumor- and lymphocyte-induced vascular responses. Cancer Res 47: 5155–5161Google Scholar
  171. Speir E, Sasse J, Shrivastav S, Casscells W (1991) Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells. J Cell Physiol 147: 362–373PubMedGoogle Scholar
  172. Sprugel KH, McPherson JM, Clowes AW, Ross R (1987) Effects of growth factors in vivo I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 129: 601–613PubMedGoogle Scholar
  173. St-Jacques S, Cymerman U, Pece N, Letarte M (1994) Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-ß binding protein of endothelial and stromal cells. Endocrinology 134: 2645–2657PubMedGoogle Scholar
  174. Stahl N, Yancopoulos GD (1993) The alphas, betas and kinases of cytokine receptor complexes. Cell 74: 587–590PubMedGoogle Scholar
  175. Stavri GT, Hong Y, Zachary IC, Breier G, Baskerville PA, Ylä-Herttuala S, Risau W, Martin JF, Erusalimsky JD (1995) Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358: 311–315PubMedGoogle Scholar
  176. Stoplen AH, Guinan EC, Fiers W, Pober JS (1986) Recombinant tumor necrosis factor and immune interferon act singly and combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 123: 16–24Google Scholar
  177. Sun WH, Kreisle RA, Phillips AW, Ershler WB (1992) In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 52: 5412–5415PubMedGoogle Scholar
  178. Symes JF, Sniderman AD (1994) Angiogenesis: potential therapy for ischemic disease. Curr Opin Lipidology 5: 305–312Google Scholar
  179. Taga T, Kishimoto T (1993) Cytokine receptors and signal transduction. FASEB J 7: 3387–3396Google Scholar
  180. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93: 2357–2364PubMedGoogle Scholar
  181. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL (1995) Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44: 98–103PubMedGoogle Scholar
  182. Tuder RM, Flook BE, Voelkel NF (1995) Increased gene expression for VEGF and the VEGF receptors KDR/flk and fit in lungs exposed to acute or chronic hypoxia. J Clin Invest 95: 1798–1807PubMedGoogle Scholar
  183. Ueba T, Takahashi JA, Fukumoto M, Ohata M, Ito N, Oda Y, Kikuchi H, Hatanaka M (1994) Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery 34: 221–226PubMedGoogle Scholar
  184. Ueki N, Nakazato M, Ohkawa T, Ikeda T, Amuro Y, Hada T, Higashino K (1992) Excessive production of transforming growth factor-ß1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim Acta 1137: 189–196Google Scholar
  185. Valente G, Ozmen L, Novelli F, Geuna M, Palestro G, Forni G, Garotta G (1992) Distribution of interferon gamma receptor in human tissues. Eur J Immunol 22: 2403–2412PubMedGoogle Scholar
  186. Vernon RB, Lara SL, Drake CJ, Iruela-Arispe ML, Angello JC, Litttle CD, Wight TN, Sage EH (1995) Organized type I collagen influences endothelial patterns during “spontaneous angiogenesis in vitro”: planar cultures as models of vascular development. In Vitro Cell Dev Biol 31: 120–131Google Scholar
  187. Vilcek J (1990) Interferons. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors II. Springer, Berlin Heidelberg New York, pp 3–38Google Scholar
  188. Volpes R, van den Oord JJ, De Vos R, Depla E, De Ley M, Desmet VJ (1991) Expression of interferon gamma receptor in normal and pathological human liver tissue. J Hepatol 12: 195–202PubMedGoogle Scholar
  189. Wahl SM, Hunt DA, Wakefield LA, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB (1987) Transforming growth factor type ß induces monocyte chamotaxis and growth factor production. Proc Natl Acad Sci USA 84: 5788–5792PubMedGoogle Scholar
  190. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H (1994) Different signal transduction properties of KDR and flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988–26995PubMedGoogle Scholar
  191. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789–1797PubMedGoogle Scholar
  192. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 320: 1197–1200PubMedGoogle Scholar
  193. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A (1991) Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118: 59–66PubMedGoogle Scholar
  194. Wilkie AOM, Morris-Kay GM, Jones EY, Health JK (1995) Functions of fibroblast growth factors and their receptors. Curr Biol 5: 500–507PubMedGoogle Scholar
  195. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ (1988) Transforming growth factor beta (TGFß) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793–800PubMedGoogle Scholar
  196. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994) Mechanism of activation of the TGF-ß receptor. Nature 370: 341–347PubMedGoogle Scholar
  197. Yamaguchi TP, Harpal K, Hankemeyer M, Rossant J (1994) fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 8: 3032–3044PubMedGoogle Scholar
  198. Yang EY, Moses HL (1990) Transforming growth factor ß1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111: 731–741PubMedGoogle Scholar
  199. Yeo K-T, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DM, Dvorak HF, Yeo T-K (1993) Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53; 2912–2918PubMedGoogle Scholar
  200. Yu Z-X, Biro S, Fu Y-M, Sanchez J; Smale G, Sasse J, Ferrans VJ, Casscells W (1993) Localization of basic fibroblast growth factor in endothelial cells: immunohistochemical and biochemical studies. Exp Cell Res 204: 247–259PubMedGoogle Scholar
  201. Zagzag D (1995) Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 146: 293–309PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. S. Pepper
    • 1
  • S. J. Mandriota
    • 1
  • J.-D. Vassalli
    • 1
  • L. Orci
    • 1
  • R. Montesano
    • 1
  1. 1.Department of MorphologyUniversity of Geneva Medical CenterGeneva 4Switzerland

Personalised recommendations